UNDERSTANDING ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL): TYPES, CAUSES, AND TREATMENT Anaplastic Large-Cell Lymphoma (ALCL) is a rare and aggressive form of non-Hodgkin lymphoma that primarily impacts ...
Implant rupture must be ruled out in the presence of a large fluid effusion surrounding the implant. Effusions that develop within 1 year of surgery may indicate a postsurgical hematoma or effusion, ...
Frontline brentuximab vedotin (BV) and CHP in patients (pts) with peripheral T-cell lymphoma (PTCL) with 10% CD30 expression: Primary analysis results from the phase 2 SGN35-032 study. Safety and ...
The Food and Drug Administration issued a warning Wednesday about a rare and deadly cancer linked to breast implants. The agency said at least 457 women in the U.S. have been diagnosed with anaplastic ...
Benefit and Timing of Second Transplantations in Multiple Myeloma: Clinical Findings and Methodological Limitations in a European Group for Blood and Marrow Transplantation Registry Study Survivin, a ...
Overall survival was significantly improved in patients treated with brentuximab vedotin plus lenalidomide/rituximab compared with placebo plus lenalidomide/rituximab ...
Recent noteworthy reports on diffuse large B-cell lymphoma (DLBCL) include positive survival results with an antibody-drug conjugate in relapsed/refractory disease, FDA issues with a randomized trial, ...
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare T‐cell lymphoma that emerges in the periprosthetic capsule surrounding breast implants, particularly those with a textured ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results